- NCIt
- C8101
Loading cancer entity…
Loading cancer entity…
Clinical trials
1,164 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01557881 | Positron Emission Tomography/Magnetic Resonance Imaging in Patients | terminated | N/A | 98 | Case Comprehensive Cancer CenterOTHER | 1 | Feb 24, 2020 | clinicaltrials |
| NCT03494231 | A Study of HLX06, a Humanized Monoclonal Antibody Targeting Human Vascular Endothelial Growth Factor Receptor-2 in Patients With Advanced Solid Tumors | terminated | Phase 1 | 5 | Henlix, IncINDUSTRY | 1 | Jul 30, 2019 | clinicaltrials |
| NCT02070406 | Gene-Modified T Cells, Vaccine Therapy, and Ipilimumab in Treating Patients With Locally Advanced or Metastatic Malignancies | terminated | Phase 1 | 4 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Feb 28, 2019 | clinicaltrials |
| NCT00814463 | Stereotactic Radiosurgery After Surgery in Treating Patients With Brain Metastases | terminated | Phase 2 | 1 | Duke UniversityOTHER | 1 | Feb 26, 2019 | clinicaltrials |
| NCT00540969 | Cryoablation or External-Beam Radiation Therapy in Treating Patients With Painful Bone Metastases | terminated | Phase 3 | 3 | Alliance for Clinical Trials in OncologyOTHER | 1 | Nov 21, 2018 | clinicaltrials |
| NCT01234922 | Benazepril Hydrochloride, Lisinopril, Ramipril, or Losartan Potassium in Treating Hypertension in Patients With Solid Tumors | terminated | Phase 2 | 6 | Wake Forest University Health SciencesOTHER | 1 | Aug 28, 2018 | clinicaltrials |
| NCT01705106 | Capecitabine and Celecoxib in Patients With Solid Cancers That Have Been Previously Treated With Standard Therapies | terminated | Phase 1 | 21 | University of ChicagoOTHER | 1 | May 30, 2018 | clinicaltrials |
| NCT02269111 | Quantitative MRI in Assessing Disease in Patients With Brain Tumors | terminated | N/A | 10 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | May 29, 2018 | clinicaltrials |
| NCT00095862 | Vaccine Therapy in Treating Patients With HER2/Neu Positive or Negative Stage IV Breast Cancer or Other HER2/Neu Positive Cancers | terminated | Phase 1 / Phase 2 | 24 | Wiseman Research Initiatives LLCINDUSTRY | 1 | Feb 5, 2018 | clinicaltrials |
| NCT00470548 | Abraxane and Alimta in Advanced Solid Tumors | terminated | Phase 1 / Phase 2 | 49 | University of California, DavisOTHER | 1 | Jan 10, 2018 | clinicaltrials |
| NCT00807755 | Everolimus, Carboplatin, and Etoposide in Treating Patients With Small Cell Lung Cancer or Other Advanced Solid Tumors | terminated | Phase 1 | 5 | University of California, DavisOTHER | 1 | Jan 9, 2018 | clinicaltrials |
| NCT00728429 | Aerobic Exercise in Patients Receiving Chemotherapy for Cancer | terminated | N/A | 1 | Wake Forest University Health SciencesOTHER | 1 | May 30, 2017 | clinicaltrials |
| NCT01893879 | Placebo-Controlled Therapeutic Trial for the Prevention of Lymphedema(PCTTPL) | terminated | N/A | 14 | Stanford UniversityOTHER | 1 | May 18, 2017 | clinicaltrials |
| NCT00217724 | Glutamine in Preventing Myalgia and/or Arthralgia in Patients Who Are Receiving Paclitaxel For Cancer | terminated | N/A | 18 | OHSU Knight Cancer InstituteOTHER | 1 | May 9, 2017 | clinicaltrials |
| NCT00258440 | Epoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy for Cancer | terminated | N/A | 7 | OHSU Knight Cancer InstituteOTHER | 1 | May 9, 2017 | clinicaltrials |
| NCT01031953 | Fosaprepitant Dimeglumine in Treating Patients With Nausea and Vomiting Caused By Chemotherapy | terminated | Phase 1 / Phase 2 | 34 | OHSU Knight Cancer InstituteOTHER | 1 | May 9, 2017 | clinicaltrials |
| NCT01098643 | Satisfaction With Placement of Implantable Venous Access Devices in Patients With Solid Tumors | terminated | N/A | 88 | Vanderbilt UniversityOTHER | 1 | Apr 4, 2017 | clinicaltrials |
| NCT00019604 | Radiofrequency Ablation in Treating Patients With Unresectable Primary or Metastatic Liver Cancer | terminated | Phase 2 | 44 | National Institutes of Health Clinical Center (CC)NIH | 1 | Feb 3, 2017 | clinicaltrials |
| NCT00550654 | Conformal Radiation Therapy in Treating Patients With Metastatic Cancer Outside the Brain | terminated | Phase 2 | 1 | National Institutes of Health Clinical Center (CC)NIH | 1 | Jan 13, 2017 | clinicaltrials |
| NCT02895490 | Communication Training in Promoting Employment Retention Among Cancer Patients | terminated | N/A | 8 | Virginia Commonwealth UniversityOTHER | 1 | Sep 20, 2016 | clinicaltrials |
| NCT00938457 | Stereotactic Radiation Therapy in Treating Patients With Liver Metastases | terminated | Phase 1 / Phase 2 | 3 | Mayo ClinicOTHER | 1 | May 19, 2016 | clinicaltrials |
| NCT01093092 | Calcitriol, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid Tumors That Cannot Be Removed by Surgery | terminated | Phase 1 | 14 | Roswell Park Cancer InstituteOTHER | 1 | Jan 12, 2016 | clinicaltrials |
| NCT00704938 | Gene-Modified Lymphocytes, High-Dose Aldesleukin, and Vaccine Therapy in Treating Patients With Progressive or Recurrent Metastatic Cancer | terminated | Phase 2 | 3 | National Institutes of Health Clinical Center (CC)NIH | 1 | Oct 28, 2015 | clinicaltrials |
| NCT00486213 | Pyridoxine in Preventing Hand-Foot Syndrome Caused by Capecitabine in Patients With Cancer | terminated | Phase 3 | 210 | National Cancer Centre, SingaporeOTHER | 1 | Sep 24, 2015 | clinicaltrials |
| NCT01122888 | Cilengitide and Sunitinib Malate in Treating Patients With Advanced Solid Tumors or Glioblastoma Multiforme | terminated | Phase 1 | 41 | National Cancer Institute (NCI)NIH | 1 | Apr 28, 2015 | clinicaltrials |
| NCT01324115 | NG-Nitro-L-Arginine in Treating Patients With Advanced Solid Tumors | terminated | Phase 1 | 6 | Cancer Research UKOTHER | 1 | Mar 5, 2015 | clinicaltrials |
| NCT01417403 | Hydroxychloroquine in Treating Patients With Solid Tumors Undergoing Radiation Therapy for Bone Metastases | terminated | Phase 1 | 10 | Virginia Commonwealth UniversityOTHER | 1 | Feb 3, 2015 | clinicaltrials |
| NCT00910039 | Sunitinib Malate After Stereotactic Radiosurgery in Treating Patients With Newly Diagnosed Brain Metastases | terminated | Phase 2 | 14 | Case Comprehensive Cancer CenterOTHER | 1 | Sep 29, 2014 | clinicaltrials |
| NCT01835184 | Cabozantinib-S-Malate and Vemurafenib in Treating Patients With Solid Tumors or Melanoma That is Metastatic or That Cannot Be Removed By Surgery | terminated | Phase 1 | 5 | National Cancer Institute (NCI)NIH | 1 | Sep 25, 2014 | clinicaltrials |
| NCT00002948 | High-Dose Topotecan and Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer | terminated | Phase 1 | — | Yale UniversityOTHER | 1 | Jul 2, 2014 | clinicaltrials |
| NCT01631279 | A Dose Escalation Trial of PR610 Treating Patients With Solid Tumors | terminated | Phase 1 / Phase 2 | 33 | Proacta, IncorporatedINDUSTRY | 2 | Jun 16, 2014 | clinicaltrials |
| NCT00003009 | Inhaled Interleukin-2 in Treating Patients With Metastatic or Unresectable Cancer | terminated | Phase 1 | 16 | University of Southern CaliforniaOTHER | 1 | May 22, 2014 | clinicaltrials |
| NCT01018836 | Riluzole and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases | terminated | Phase 1 | 9 | Rutgers, The State University of New JerseyOTHER | 1 | May 2, 2014 | clinicaltrials |
| NCT01233505 | Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors | terminated | Phase 1 | 16 | National Cancer Institute (NCI)NIH | 1 | Apr 2, 2014 | clinicaltrials |
| NCT00096005 | Tanespimycin and Bortezomib in Treating Patients With Advanced Solid Tumors or Lymphomas | terminated | Phase 1 | 36 | National Cancer Institute (NCI)NIH | 1 | Feb 24, 2014 | clinicaltrials |
| NCT00112684 | Alvocidib in Treating Patients With Locally Advanced or Metastatic Solid Tumors | terminated | Phase 1 | 25 | National Cancer Institute (NCI)NIH | 1 | Feb 24, 2014 | clinicaltrials |
| NCT00436579 | Sorafenib in Treating Patients With Advanced Solid Tumors | terminated | Phase 1 | 110 | National Cancer Institute (NCI)NIH | 1 | Feb 24, 2014 | clinicaltrials |
| NCT00701298 | Decitabine With or Without Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Solid Tumors | terminated | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Feb 24, 2014 | clinicaltrials |
| NCT00019708 | Geldanamycin Analogue in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma | terminated | Phase 1 | 45 | National Cancer Institute (NCI)NIH | 1 | Dec 16, 2013 | clinicaltrials |
| NCT00070239 | Alvocidib in Treating Patients With Metastatic or Unresectable Refractory Solid Tumors or Hematologic Malignancies | terminated | Phase 1 | 100 | National Cancer Institute (NCI)NIH | 1 | Dec 16, 2013 | clinicaltrials |
| NCT00369200 | AFP464 in Treating Patients With Advanced Solid Tumors | terminated | Phase 1 | 60 | National Cancer Institute (NCI)NIH | 1 | Dec 11, 2013 | clinicaltrials |
| NCT00811655 | Stereotactic Radiosurgery in Treating Patients With Brain Metastases | terminated | Phase 2 | 6 | Duke UniversityOTHER | 1 | Nov 25, 2013 | clinicaltrials |
| NCT01159301 | Entinostat and Sorafenib Tosylate in Treating Patients With Advanced or Metastatic Solid Tumors or Refractory or Relapsed Acute Myeloid Leukemia | terminated | Phase 1 | 44 | National Cancer Institute (NCI)NIH | 1 | Sep 19, 2013 | clinicaltrials |
| NCT00504205 | MP470 in Treating Patients With Unresectable or Metastatic Solid Tumor or Lymphoma | terminated | N/A | 30 | Astex Pharmaceuticals, Inc.INDUSTRY | 1 | Aug 2, 2013 | clinicaltrials |
| NCT00012194 | 7-hydroxystaurosporine and Cisplatin in Treating Patients With Advanced Malignant Solid Tumors | terminated | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Jul 9, 2013 | clinicaltrials |
| NCT00009958 | Vaccine Therapy With or Without Sargramostim in Treating Patients With Cancer | terminated | Phase 1 | 42 | National Cancer Institute (NCI)NIH | 1 | May 16, 2013 | clinicaltrials |
| NCT00354185 | PXD101 and 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphoma | terminated | Phase 1 | 36 | National Cancer Institute (NCI)NIH | 1 | May 16, 2013 | clinicaltrials |
| NCT00899951 | Studying Fentanyl in Patients With Cancer | terminated | — | 2 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Apr 18, 2013 | clinicaltrials |
| NCT01096407 | Role of Biomarkers in Muscle Pain and Joint Pain in Patients With Solid Tumors Receiving Paclitaxel | terminated | — | 5 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Apr 4, 2013 | clinicaltrials |
| NCT01602627 | Hsp90 Inhibitor AUY922 in Treating Older Patients With Advanced Solid Malignancies | terminated | Phase 1 | 2 | Dale Shepard, MD, PhDOTHER | 1 | Feb 7, 2013 | clinicaltrials |
Data updated 22 days agoSource updated Feb 24, 2020source: clinicaltrials